Axsome and Hetero settle patent fight over sleep disorder drug
Hetero Labs could launch its generic sleep disorder drug as early as 2040 under a settlement deal with Axsome Therapeutics. The settlement, announced Tuesday, resolves patent litigation between Axsome and Hetero in the New Jersey ...
Hetero Labs could launch its generic sleep disorder drug as early as 2040 under a settlement deal with Axsome Therapeutics.
The settlement, announced Tuesday, resolves patent litigation between Axsome and Hetero in the New Jersey ...
